Barr
Executive Summary
Authorized generic tamoxifen (Zeneca's Nolvadex) distributor files a motion to become a plaintiff-intervenor in Zeneca's federal lawsuit against Lilly alleging false and misleading promotion of Evista (raloxifene) for breast cancer. A hearing for the case is schedule for May 17 (1"The Pink Sheet" March 1, p. 27)